Evaxion Biotech A/S (EVAX) SEC News Oct. 30, 2025, 12:15 UTC (99% Neutral) Evaxion Biotech A/S (EVAX) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 30, 2025, 1:57 p.m. 🌍 Evaxion Biotech A/S (EVAX) - Form 6-K Filing Filing Date: 2025-10-30 Accepted: 2025-10-30 08:15:05 Event Type: Clinical Trial Update Event Details: htm PRESS RELEASE EdgarFilingEXHIBIT 99. 5 million and exercise of warrants providing a further $2. 5 million paid by MSD (tradename of Merck Co. 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported✅ Licensing Agreement✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Email: mak@evaxion.ai
🌍 Evaxion Biotech A/S (EVAX) - Form 6-K Filing
Filing Date: 2025-10-30
Accepted: 2025-10-30 08:15:05
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: